Cnbx Pharmaceuticals Inc.

CNBX

Financials

10-QQ3 ended 05/31/2606/24/26 10-QQ2 ended 02/28/2604/14/26 10-QQ1 ended 11/30/2501/14/26 10-KFY 202512/01/25 10-QQ3 ended 05/31/2507/14/25

Disclosures

8-KCurrent report10/01/26 8-KCurrent report03/17/26 8-KCurrent report01/30/25 8-KCurrent report03/22/24 8-KCurrent report02/08/23

Prospectuses and Registrations

S-1Registration statement (IPO)02/18/22 S-1Registration statement (IPO)05/10/21 S-1/ARegistration statement (amended)02/23/21 S-1Registration statement (IPO)01/27/21 424B5Prospectus supplement09/26/18

Proxies

DEF 14CDefinitive information statement02/15/22 PRE 14CPRE 14C02/04/22 DEF 14CDefinitive information statement08/11/10 PRE 14CPRE 14C07/30/10

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)05/08/26 SC 13G/ABeneficial ownership (amended)02/05/26 SC 13G/ABeneficial ownership (amended)11/10/25 SC 13G/ABeneficial ownership (amended)08/13/25

Other

UPLOADLetter from the SEC06/17/24 CORRESPCorrespondence with the SEC06/06/24 UPLOADLetter from the SEC05/30/24 CORRESPCorrespondence with the SEC05/21/24 UPLOADLetter from the SEC04/22/24